Fingerprint
Dive into the research topics of 'Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Talha Badar, Damian R. Handisides, Juliana M. Benito, Mary Ann Richie, Gautam Borthakur, Elias Jabbour, Karine Harutyunyan, Sergej Konoplev, Stefan Faderl, Stew Kroll, Michael Andreeff, Tillman Pearce, Hagop M. Kantarjian, Jorge E. Cortes, Deborah A. Thomas, Marina Konopleva
Research output: Contribution to journal › Article › peer-review